​
Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service
Team. 
You can expect a reply from us within 5 working days for a straightforward
request. Where a more detailed response or contribution from a specialist
is required this is likely to take longer but we will inform you of this.
Please note that we may not respond if your query:
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only
Medicines and Healthcare products Regulatory Agency
10 South Colonnade,
Canary Wharf,
London
E14 4PU
gov.uk/mhra
Stay connected
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC.
The UK has left the EU, and the transition period ends on 31 December
2020. Click here to find out more.

Our Ref: FOI 20/576

Dear Anna Frances,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 23 December 2020.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Kind Regards,


MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

show quoted sections

FOI 20/576
 
Dear Anna Frances,
 
Thank you for your email.
 
The list of ingredients in the Pfizer/BioNTech vaccine is available in the
Information for healthcare professionals and the Information for UK
recipients of the vaccine, see links below:
[1]https://assets.publishing.service.gov.uk...
[2]https://assets.publishing.service.gov.uk...
 
Information concerning the isolation of the Covid-19 virus is available as
part of the Scientific Advisory Group for Emergencies (SAGE) website, a
link to the website is provided below:
[3]https://www.gov.uk/government/organisati...
 
Regarding approved swine flu vaccines, two vaccines were approved for the
H1N1 virus by the European Medicines Agency (EMA) in 2009, further details
(including the composition of each vaccine) are provided below:
[4]https://www.ema.europa.eu/en/news/europe...
 
Regarding any damages paid out by the UK government following
administration of either swine flu vaccine, MHRA holds no information on
this.
 
With regards to both vaccines for H1N1, Focetria and Pandemrix, documents
published on the EMA website state that both products were discontinued
because of a lack of demand.
 
If you are dissatisfied with the handling of your request, you have the
right to ask for an internal review.
Internal review requests should be submitted within two months of the date
you receive this response and addressed to: [5][MHRA request email] .
 
Please remember to quote the reference number above in any future
communications. Please note, due to the ongoing Covid-19 situation, we are
not able to accept delivery of any documents or correspondence by post or
courier to any of our offices.
 
If you were to remain dissatisfied with the outcome of the internal
review, you would have the right to apply directly to the Information
Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless
you have first contacted us to conduct an internal review. The Information
Commissioner can be contacted at:
 
Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
 
Yours sincerely,
 
 
MHRA Customer Service Centre
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000
 

show quoted sections